Why Postpartum Preeclampsia Is Easy to Miss
Most pregnant patients are counseled extensively about preeclampsia in the third trimester: regular blood pressure checks, urine protein assessments, and a low threshold to call about new headaches or visual changes. After delivery, the cultural script shifts. Discharge instructions emphasize bleeding, breastfeeding, and pain control; preeclampsia counseling often shrinks to a sentence. Yet the American College of Obstetricians and Gynecologists (ACOG) describes a clearly defined postpartum risk window extending up to 6 weeks after delivery. New-onset hypertension, proteinuria, and end-organ dysfunction can appear de novo in this period — sometimes in patients whose prenatal blood pressures were entirely normal. The CDC's review of pregnancy-related deaths consistently highlights postpartum hypertensive disorders as a leading contributor to maternal mortality, and a substantial fraction of those deaths involve patients who left the hospital before symptoms developed and did not recognize the warning signs at home. The pathophysiology is the same as antepartum preeclampsia: a placental-driven cascade of endothelial dysfunction that does not fully resolve at delivery and can intensify in the days that follow as fluid shifts and inflammatory mediators evolve.
A subtle pattern that appears repeatedly in case reviews is the patient who attributes a worsening postpartum headache to dehydration, sleep deprivation, or breastfeeding stress, and who does not measure blood pressure because home equipment is buried in a closet. The functional rule the Wermom medical team teaches: if you are postpartum and have any headache that is unusual for you, take your blood pressure before you take acetaminophen. The order matters. A normal BP with a headache that responds to acetaminophen is reassuring; a BP in the severe range is an emergency department finding regardless of how the headache feels. This single sequencing change converts the home cuff from a vague accessory into a meaningful decision tool.
ACOG's Specific Red-Flag List That Should Trigger an ER Visit
ACOG Practice Bulletin 222 and the Society for Maternal-Fetal Medicine guidance on hypertensive disorders identify symptoms that should not be triaged into the next-day clinic queue. These include severe headache that does not respond to standard doses of acetaminophen; new visual changes such as scotomata, blurred vision, or transient vision loss; right-upper-quadrant or epigastric pain that is persistent or moderate-to-severe (often confused with reflux or post-delivery soreness); shortness of breath, which can signal pulmonary edema; markedly reduced urine output; and any home blood pressure reading ≥160/110 mmHg on two measurements 15 minutes apart. The reason these are emergency-department-level findings, rather than messages for the on-call nurse, is that severe-range hypertension warrants treatment within 30–60 minutes to reduce the risk of stroke. Magnesium sulfate for seizure prophylaxis is initiated in the inpatient setting; IV antihypertensives — labetalol, hydralazine, or oral nifedipine — are titrated against measured pressures. None of those can be delivered from home. Patients are often hesitant to 'overreact' in the early weeks; the consistent feedback from maternal-fetal medicine teams is that delayed presentation is the dominant pattern in adverse outcomes, not over-presentation.
Many emergency departments now apply standardized pathways for postpartum hypertensive presentations precisely because the diagnosis used to be missed. If you arrive at an ED in the first six weeks after delivery with a headache, visual change, or BP ≥160/110, you should expect a rapid workup that includes a urine protein assessment, basic labs (CBC, comprehensive metabolic panel, possibly LDH and uric acid), and a clear plan for either inpatient admission for monitoring and magnesium sulfate or discharge with explicit follow-up. If the workup does not include these elements and the team appears to be treating you as if you were a non-postpartum patient with hypertension, it is appropriate to ask explicitly: 'Is this being evaluated as postpartum preeclampsia?'
Who Is at Highest Risk in the Postpartum Window
Risk factors mirror antepartum preeclampsia and accumulate. Pre-pregnancy chronic hypertension, pregestational diabetes, BMI ≥30, kidney disease, autoimmune conditions (notably lupus and antiphospholipid syndrome), and a history of preeclampsia in a prior pregnancy all elevate risk. First pregnancies, pregnancies with assisted reproductive technology, and pregnancies complicated by gestational hypertension that did not progress to preeclampsia before delivery are also higher-risk. Race-based disparities are well documented: Black patients in the United States experience higher rates of severe maternal morbidity and mortality related to hypertensive disorders, and CDC analyses point to delayed diagnosis and undertreatment as significant contributing factors. Excess intravenous fluid administration during labor and delivery — particularly in the setting of severe-range pressures — has been associated with postpartum pulmonary edema and is a modifiable contributor that obstetric teams are actively addressing through fluid stewardship protocols. The practical implication: a patient with even one or two risk factors should be offered a home blood pressure cuff, an explicit 'call us at 160/110' instruction, and a low threshold for a 7–10-day blood pressure check rather than the traditional 6-week visit alone.
Disparities in this area are not abstract. CDC analyses of pregnancy-related deaths consistently identify hypertensive disorders of pregnancy as a leading cause, and Black patients in the United States experience disproportionate mortality from this category. The contributing factors are well-described — delayed recognition of warning signs, fewer postpartum touchpoints, fewer follow-up phone-call interventions, and documented bias in how pain and symptoms are weighted. Patients in higher-risk groups should ask explicitly at discharge whether a home BP cuff is being provided, whether a structured 7–10-day check is scheduled, and what number to call after hours. Programs that provide these supports demonstrably close the outcome gap; programs that omit them do not.
Home Blood Pressure Monitoring: What the Evidence Supports
Programs that send patients home with validated automated cuffs and a structured monitoring schedule have demonstrated meaningful reductions in delayed presentation. The University of Pennsylvania's Heart Safe Motherhood program, for example, paired home BP measurement with text-message-based follow-up and showed dramatic improvements in postpartum monitoring engagement among Black patients compared with the historical 6-week clinic-only model. ACOG now recommends in-person or remote blood pressure assessment within 7–10 days postpartum — earlier, within 72 hours, for patients with hypertensive disorders during pregnancy. A reasonable home monitoring schedule for any patient with hypertensive history is twice daily for the first two weeks, then daily through six weeks, with clear thresholds: any single reading ≥160/110 mmHg, or persistent readings ≥140/90 mmHg, warrants a call. Pairing measurements with symptoms is critical — many patients with severe-range pressures feel completely well, which is exactly why measurement matters. Cuffs validated for accuracy (look for AAMI/BHS/ESH validation) are widely available; the wrist cuffs many patients purchase casually are generally less accurate and not the first choice.
Home blood pressure monitoring done well looks like this: a validated upper-arm automated cuff (not wrist), placed at heart level, in a quiet position after five minutes of rest. Two readings are taken, 1–2 minutes apart, and recorded in a phone note or paper log with timestamp. If two consecutive readings on the same arm are in the severe range, the patient calls and proceeds to the emergency department. If pressures are in the mild-to-moderate elevated range (140–159 / 90–109), the patient calls the OB practice for guidance — most teams will start or adjust antihypertensive medication and arrange an in-person check. The cadence of measurement and the threshold for action are the parts that most home programs underspecify.
What Wermom's Editorial Team Sees as the Most Common Counseling Gap
The pattern that repeats across reader questions on this topic is not lack of clinician awareness — it is mismatch between discharge counseling and the patient's actual symptom-recognition vocabulary. Patients leave the hospital exhausted, often with a sleeping newborn in their arms, and are told to watch for 'severe headaches' without operationalizing what severe means. The Wermom medical advisor team's preferred framing: a headache is concerning if it is the worst you have had during this pregnancy, if it is not relieved by your usual dose of acetaminophen within an hour, or if it is paired with any of vision changes, RUQ pain, shortness of breath, or facial swelling. Similarly, RUQ pain often gets attributed to gas, reflux, or muscle soreness from holding the baby; the right discriminator is whether the pain is persistent for more than an hour and not relieved by changing position. None of this replaces medical evaluation; it provides a clearer rule for when to seek it. Pair this with a home BP cuff and an early 7–10-day touchpoint, and the postpartum preeclampsia window becomes far less invisible than it has historically been.
Wermom's medical advisor team consistently sees that the patients who do best in this window are not the ones with the most aggressive symptoms — they are the ones with the clearest plan. A laminated card on the fridge listing the BP threshold to call, the symptom threshold to call, the after-hours number, and the nearest emergency department's name converts an abstract checklist into a concrete one. Postpartum is a sleep-deprived, decision-fatigued period in which any plan that requires recall is a fragile plan. Partners and family members should also know the warning signs, because the patient who is most affected by severe hypertension may be the least able to recognize the symptoms in real time.